Author

Sebastian Reinartz

University of ColognePrimary ORCID profile (0000-0002-7273-0796 · 4 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Sebastian ReinartziD4 papers · Scuola Internazionale Superiore di Studi Avanzati

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Michael J. HallekiD· 2 shared Natascha RoseniD· 2 shared Nina Reinart· 2 shared Phuong‐Hien NguyeniD· 2 shared Viktoria KohlhasiD· 2 shared Alexander F. vom SteiniD· 1 shared Alexandra FloriniD· 1 shared Guillermo Rodríguez‐RealiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Michael J. HallekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular source

Viktoria Kohlhas, Nina Reinart, Natascha Rosen, Sebastian Reinartz, Alexandra Florin, Thanh Tung Truong, Luca D Schreurs, Phuong‐Hien Nguyen, Michael J. Hallek

This study shows that systemic MIF is critical for CLL development, regardless of its cellular source, as Mif-deficient hosts resist disease despite adaptive transfer of CLL cells.

Journal of Leukocyte Biology · Nov 28, 2025Peer-reviewedCancer Biology

Reduced CSF1R expression in myeloid cells has limited impact on chronic lymphocytic leukemia progression

Natascha Rosen, Guillermo Rodríguez‐Real, Viktoria Kohlhas, Thanh-Tung Truong, Alexander F. vom Stein, Maximilian Koch, Sebastian Reinartz, Sumiya Iqbal, Shaista Ilyas, Sanjay Mathur, Nina Reinart, Phuong‐Hien Nguyen, Michael J. Hallek

This study shows that reducing CSF1R expression in myeloid cells has limited impact on CLL progression, suggesting that targeting CSF1R alone may not be effective for therapy.

bioRxiv · Oct 7, 2025 · PreprintCancer Biology